153 related articles for article (PubMed ID: 24935573)
1. Application of tumor markers SCC-Ag, CEA, and TPA in patients with cervical precancerous lesions.
Farzaneh F; Shahghassempour S; Noshine B; Arab M; Yaseri M; Rafizadeh M; Alizadeh K
Asian Pac J Cancer Prev; 2014; 15(9):3911-4. PubMed ID: 24935573
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment plasma levels and diagnostic utility of hematopoietic cytokines in cervical cancer or cervical intraepithelial neoplasia patients.
Ławicki S; Będkowska GE; Gacuta-Szumarska E; Knapp P; Szmitkowski M
Folia Histochem Cytobiol; 2012 Jul; 50(2):213-9. PubMed ID: 22763962
[TBL] [Abstract][Full Text] [Related]
3. Determination of serum levels of different cytokeratins in patients with uterine malignancies.
Ferdeghini M; Gadducci A; Prontera C; Castellani C; Annicchiarico C; Gagetti O; Facchini V; Bianchi R
Anticancer Res; 1994; 14(3B):1393-7. PubMed ID: 7520682
[TBL] [Abstract][Full Text] [Related]
4. Both TPA and SCC-Ag levels are prognostic even in high-risk stage Ib-IIa cervical carcinoma as determined by a stratification analysis.
Yuan CC; Wang PH; Ng HT; Tsai LC; Juang CM; Chiu LM
Eur J Gynaecol Oncol; 2002; 23(1):17-20. PubMed ID: 11876385
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of M-CSF and VEGF in laboratory diagnostics and differentiation of selected histological types of cervical cancers.
Sidorkiewicz I; Zbucka-Krętowska M; Zaręba K; Lubowicka E; Zajkowska M; Szmitkowski M; Gacuta E; Ławicki S
BMC Cancer; 2019 Apr; 19(1):398. PubMed ID: 31035945
[TBL] [Abstract][Full Text] [Related]
6. The clinical values of squamous cell carcinoma antigen and carcinoembryonic antigen in patients with cervical cancer treated with concurrent chemoradiotherapy.
Yoon SM; Shin KH; Kim JY; Seo SS; Park SY; Kang S; Cho KH
Int J Gynecol Cancer; 2007; 17(4):872-8. PubMed ID: 17343571
[TBL] [Abstract][Full Text] [Related]
7. Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigen.
Bonfrer JM; Gaarenstroom KN; Korse CM; Van Bunningen BN; Kenemans P
Anticancer Res; 1997; 17(3C):2329-34. PubMed ID: 9245246
[TBL] [Abstract][Full Text] [Related]
8. Significance of elevated SCC-Ag level on tumor recurrence and patient survival in patients with squamous-cell carcinoma of uterine cervix following definitive chemoradiotherapy: a multi-institutional analysis.
Choi KH; Lee SW; Yu M; Jeong S; Lee JW; Lee JH
J Gynecol Oncol; 2019 Jan; 30(1):e1. PubMed ID: 30479085
[TBL] [Abstract][Full Text] [Related]
9. Serum SCC-Ag in head and neck squamous cell carcinoma.
Palermo F; Carniato A; Fede A; Boccaletto F; Marchiori C
Int J Biol Markers; 1990; 5(3):118-20. PubMed ID: 2286775
[TBL] [Abstract][Full Text] [Related]
10. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of carcinoembryonic antigen, tissue polypeptide antigen, and squamous cell carcinoma antigen in the detection of cervical cancers.
Lam CP; Yuan CC; Jeng FS; Tsai LC; Yeh SH; Ng HT
Zhonghua Yi Xue Za Zhi (Taipei); 1992 Jul; 50(1):7-13. PubMed ID: 1326391
[TBL] [Abstract][Full Text] [Related]
12. Optimized Cutoff Value of Serum Squamous Cell Carcinoma Antigen Concentration Accurately Predicts Recurrence After Curative Resection of Squamous Cell Carcinoma of the Esophagus.
Kanda M; Koike M; Shimizu D; Tanaka C; Kobayashi D; Hattori N; Hayashi M; Omae K; Yamada S; Nakayama G; Kodera Y
Ann Surg Oncol; 2020 Apr; 27(4):1233-1240. PubMed ID: 31650302
[TBL] [Abstract][Full Text] [Related]
13. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer.
Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ
Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459
[TBL] [Abstract][Full Text] [Related]
14. Serum concentrations of squamous-cell carcinoma antigen and tissue polypeptide antigen in the follow-up of patients with vulvar cancer.
Hefler L; Frischmuth K; Heinze G; Sliutz G; Leodolter S; Reinthaller A; Kainz C; Tempfer C
Int J Cancer; 1999 Oct; 83(2):167-70. PubMed ID: 10471522
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of pretreatment carcinoembryonic antigen after definitive radiotherapy with or without concurrent chemotherapy for squamous cell carcinoma of the uterine cervix.
Huang EY; Hsu HC; Sun LM; Chanchien CC; Lin H; Chen HC; Tseng CW; Ou YC; Chang HY; Fang FM; Huang YJ; Wang CY; Lu HM; Tsai CC; Ma YY; Fu HC; Wang YM; Wang CJ
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1105-13. PubMed ID: 20932670
[TBL] [Abstract][Full Text] [Related]
16. Serum levels and positive rates of tumor biomarkers in oral precancer patients.
Wu YH; Lin PY; Yang JH; Kuo YS; Wu YC
J Formos Med Assoc; 2021 Jun; 120(6):1324-1331. PubMed ID: 33581964
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of pretreatment serum levels of squamous cell carcinoma antigen and CA 125 in cervical carcinoma.
Avall-Lundqvist EH; Sjövall K; Nilsson BR; Eneroth PH
Eur J Cancer; 1992; 28A(10):1695-702. PubMed ID: 1389488
[TBL] [Abstract][Full Text] [Related]
18. Postreatment squamous cell carcinoma antigen as a survival prognostic factor in patients with locally advanced cervical cancer. A Spanish multicenter study. The SEGO Spain-GOG group.
Benito V; Lubrano A; Pérez-Regadera JF; Torné A; Gil-Moreno A; Tejerizo-Garcia Á; Vergés R; Díaz-Feijoo B;
Gynecol Oncol; 2021 Aug; 162(2):407-412. PubMed ID: 34119366
[TBL] [Abstract][Full Text] [Related]
19. CEA, TPA, CA 19-9, SCC and CYFRA at diagnosis and in the follow-up of anal canal tumors.
Indinnimeo M; Reale MG; Cicchini C; Stazi A; Fiori E; Izzo P
Int Surg; 1997; 82(3):275-9. PubMed ID: 9372374
[TBL] [Abstract][Full Text] [Related]
20. Can serial evaluation of serum SCC-Ag-level predict tumor recurrence and patient survival in squamous-cell carcinoma of uterine cervix treated with definitive chemoradiotherapy? A multi-institutional analysis.
Choi KH; Yu M; Jeong S; Lee JH
Int J Clin Oncol; 2020 Jul; 25(7):1405-1411. PubMed ID: 32221801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]